![](https://news.europawire.eu/wp-content/uploads/2020/04/sanofi-acts-144x144.jpg)
Sanofi to provide Plaquenil® (hydroxychloroquine) wherever possible, while securing appropriate supply levels for current approved indications; The company already increased its production capacity by 50% and is on track to further increase production over the coming months; Ongoing global clinical … Read the full press release